Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for aTyr Pharma Inc have a median target of 21.00, with a high estimate of 35.00 and a low estimate of 9.00. The median estimate represents a 1,022.99% increase from the last price of 1.87.
High | 1,771.7% | 35.00 |
Med | 1,023.0% | 21.00 |
Low | 381.3% | 9.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | -1.98% |
Average growth rate | +31.42% |
More ▼
Revenue history & estimates in USD
Average growth rate | -100.00% |
Average growth rate | +726.96% |
More ▼